Enhanced physical stability of amorphous drug formulations via dry polymer coating

Journal of Pharmaceutical Sciences

Volumn 104, Issue 6, 2015, Pages 2076-2084

  Capece, Maxx ^a   Davé, Rajesh ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

amorphization; Amorphous; coating; crystallization; dry polymer coating; formulation; physical stability; surface enhanced crystallization

Indexed keywords

POLYMER; POVIDONE; ANALGESIC AGENT; CARNAUBA WAX; EXCIPIENT; PARACETAMOL; WAX;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DYNAMICS; PARTICLE SIZE; PHARMACEUTICS; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION; CHEMISTRY; KINETICS; MEDICINAL CHEMISTRY; PROCEDURES; SOLUBILITY; SURFACE PROPERTY;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG STABILITY; EXCIPIENTS; KINETICS; PARTICLE SIZE; POLYMERS; SOLUBILITY; SURFACE PROPERTIES; WAXES;

EID: 84929170899     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24451     Document Type: Article

References (31)

1. Leuner C, Dressman J,. 2000. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 50: 47-60.
2. Yu L., 2001. Amorphous pharmaceutical solids: Preparation, characterization, and stabilization. Adv Drug Deliv Rev 48: 27-42.
3. Cai T, Zhu L, Yu L,. 2011. Crystallization of organic glasses: Effect of polymer additives on bulk and surface crystal growth in amorphous nifedipine. Pharm Res 28: 2458-2466.
4. Kestur U, Taylor L,. 2013. Evaluation of the crystal growth rate of felodipine polymorphs in the presence and absence of additives as a function of temperature. Crystal Growth Des 13: 4349-4354.
5. Kestur U, Ivanesivic I, Alonzo D, Taylor L,. 2013. Influence of particle size on the crystallization kinetics of amorphous felodipine powders. Powder Technol 236: 197-204.
6. Wu T, Yu L,. 2006. Surface crystallization of indomethacin below Tg. Pharm Res 23: 2350-2355.
7. Zhu L, Letitia W, Yu L,. 2008. Surface-enhanced crystallization of amorphous nifedipine. Mol Pharm 5: 921-926.
8. Zhu L, Jona J, Nagapudi K, Wu T,. 2010. Fast surface crystallization of amorphous griseofulvin below Tg. Pharm Res 27: 1558-1567.
9. Brian C, Yu L,. 2013. Surface self-diffusion of organic glasses. J Phys Chem 117: 13303-13309.
10. Zhu L, Brian C, Swallen, Straus P, Ediger M, Yu L,. 2011. Surface self-diffusion of an organic glass. Phys Rev Lett 106: 256103.
11. Laitinen R, Lobmann K, Strachan C, Grohganz H, Rades T,. 2013. Emerging trends in the stabilization of amorphous drugs. Int J Pharm 453: 65-79.
12. Sun Y, Zhu L, Wu T, Cai T, Gunn E, Yu L,. 2012. Stability of amorphous pharmaceutical solids: Crystal growth mechanisms and effect of polymer additives. AAPS J 14: 380-388.
13. Zhang F, Aaltonen J, Tian F, Saville D, Rades T,. 2009. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin. Eur J Pharm Biopharm 71: 64-70.
14. Bosselmann S, Owens III D, Kennedy R, Herpin M, Williams III R,. 2011. Plasma deposited stability enhancement coating for amorphous ketoprofen. Eur J Pharm Biopharm 78: 67-74.
15. Wu T, Sun Y, Li N, Villiers M, Yu L,. 2007. Inhibiting surface crystallization of amorphous indomethacin by nanocoating. Langmuir 23: 5148-5153.
16. Lust A, Lakio S, Vintsevits, Kozlova J, Veski P, Heinamaki J, Kogermann K,. 2013. Water-mediated solid-state transformation of a polymorphic drug aqueous-based drug-layer coating of pellets. Int J Pharm 456: 41-48.
17. Nikowitz K, Pintye-Hodi K, Regdon G Jr,. 2013. Study of the recrystallization in coated pellets-Effect of coating on API crystallinity. Eur J Pharm Sci 48: 563-571.
18. Puri V, Dantuluri A, Bansal A,. 2012. Barrier coated drug layered particles for enhanced performance of amorphous solid dispersions dosage form. J Pharm Sci 101: 342-353.
19. Baird J, Errdenbrugh B, Taylor L,. 2010. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci 99: 3787-3806.
20. Burea M, Levi G, Karel M,. 1992. Glass transition in poly(vinylpyrrolidone): Effect of molecular weight and dilutents. Biotechnol Prog 8: 144-148.
21. Avrami M,. 1939. Kinetics of phase change I, general theory. J Chem Phys 7: 1103-1114.
22. Miyazaki T, Yoshioka S, Aso Y, Kojima S,. 2004. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J Pharm Sci 93: 2710-2717.
23. Breitenbach J,. 2002. Melt extrusion: From process to drug delivery technology. Eur J Pharm Biopharm 54: 107-117.
24. Shah S, Maddineni S, Lu J, Repka M,. 2013. Melt extrusion with poorly soluble drugs. Int J Pharm 453: 233-252.
25. Iwasaki T, Kim J, Mizuhashi S, Satoh M,. 2005. Encapsulation of lead-free Sn/Zn/Bi solder alloy particles by coating with wax powder for improving oxidation resistance. J Electron Mater 34: 647-654.
26. Kim J, Satoh M, Iwasaki T,. 2003. Mechanical-dry coating of wax onto copper powder by ball milling. Mater Sci Eng A342: 258-263.
27. Mujumdar A, Wei D, Dave R, Pfeffer R, Wu C,. 2004. Improvement of humidity resistance of magnesium powder using dry particle coating. Powder Technol 140: 86-97.
28. Wang P, Zhu L, Teng S, Zhang Q, Young M, Gogos C,. 2009. A novel process for simultaneous milling and coating of particulates. Powder Technol 193: 65-68.
29. Young M, Gogos C, Yang J, Dave R, Zhu L, Bonnett P, Schepige W,. 2012. Continuous high speed coating of finely ground particles. Patent US 8,252,370.
30. Zhang Q, Wang P, Teng S, Qian Z, Zhu L, Gogos C,. 2010. Simultaneous milling and coating of inorganic particulates with polymeric coating materials using a fluid energy mill. Polym Sci Sci 50: 2366-2374.
31. Powell T, Cau Ting, Hasebe M, Gunn E, Gao P, Zhang G, Gong Y, Yu L,. 2013. Low-concentration polymers inhibit and accelerate crystal growth in organic glasses in correlation with segmental mobility. J Phys Chem B 117: 10334-10341.